PHENOMAPS

Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Mar 2023)

What this means for you

This application is over — abandoned 13 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90379489
Mark type
Stylized text
Filed
14 Dec 2020
Published for opposition
14 Dec 2021
Abandoned
13 Mar 2023
Attorney of record
Christina M. Licursi

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation

Owner

Prosecution history

  • 25 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 25 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 25 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 13 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 13 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 04 Jan 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 05 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Aug 2022 — SOU EXTENSION 1 GRANTED
  • 03 Aug 2022 — SOU EXTENSION 1 FILED
  • 03 Aug 2022 — SOU TEAS EXTENSION RECEIVED
  • 08 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 14 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 14 Dec 2021 — PUBLISHED FOR OPPOSITION
  • 24 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 08 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER

View this trademark record on Marksy